# FDA EIR - Gilead Sciences, Inc. - December 17, 2021

Source: https://www.globalkeysolutions.net/records/eir/gilead-sciences-inc/d3233786-7ce8-48dc-a49a-3d9c19ea2e0b

> FDA EIR for Gilead Sciences, Inc. on December 17, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Gilead Sciences, Inc.
- Inspection Date: 2021-12-17
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Officers

- [recipient](https://www.globalkeysolutions.net/people/edward-e-bjurstrom/012063fc-c545-4809-9bbb-d030242052e9)
- [recipient](https://www.globalkeysolutions.net/people/gerard-m-jensen/0277014c-bcd1-49a6-ba28-e58173ff8afd)
- [company_representative](https://www.globalkeysolutions.net/people/sue-liu/18c3d846-f404-4008-b723-a6604e2e50eb)
- [Sales Store Checker](https://www.globalkeysolutions.net/people/james-b-arnett/1d316c56-fe53-40d5-90f9-ddf04c488aa8)
- [company_representative](https://www.globalkeysolutions.net/people/keith-beechler/54602196-c515-40b3-b511-442053ed22ae)

Company: https://www.globalkeysolutions.net/companies/gilead-sciences-inc/aef302cf-d6ca-423c-8e9a-4529b8be42ea

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6